CAH · sample dossier
Cardinal Health, Inc.
58/100
FreshGenerated Oct 31, 2026 · 10:00 AM UTC · 4 hours ago
This copy is frozen (Oct 31). Sign in to run the same work — filings, valuation, bull and bear, sources — on any US stock or ETF, in about 90 seconds.
Run a fresh dossierCAH
EquityCardinal Health, Inc. · XNYS
Decision context
Recommendation
Balanced between solid Momentum (94/100) and constrained Quality (33/100).
A mixed picture — no strong reason to buy or sell right now.
AlphaDog Fair Value
Executive thesis & key metrics
Executive Thesis
Strong momentum (93.5/100), but base target implies 6.2% upside — P/E 34.6x.
Key Metrics to Watch
What changed recently
No material changes found in the last 30 days.
Why this rating
Score 58 · Hold
Data through
FreshJun 30, 2026
Momentum 94/100 — 1Y return 52%.
Re-evaluate if
- Net margin falls below -4.3% (was 0.7%)
Trim / reconsider if
- ROA falls below 2.4% (was 3.7%)
Think of these dollars as a map of our value estimate for Hold — helpful context, not a reason to override the view.
A Calmer Look · Devil's Advocate
Both sides of the Cardinal Health, Inc. story, next to the Hold above
Nothing stood out enough for a second opinion on this run.
Market context
Snapshot returns at report publication
1 month
+8.9%
3 months
+6.3%
6 months
+28.3%
1 year
+52.3%
At a Glance
A large company is riding a strong uptrend at growth-style pricing.
Top Holders
As of Jun 30, 2026Financial trajectory
Financial Performance
Go deeper
For learning and research only — not investment advice. AlphaDog doesn’t hold stocks and isn’t your financial advisor.
Run the next one yourself.
You just read a full CAH dossier — scored verdict, valuation, and both sides, with sources. Sign in to run that on a name you hold, on current filings. A free account includes 10 credits a week, 1 per fresh run.